Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1260540.RA9ys5KJRxwk5fwIMW2mFXrkcjNWxtjnxbqMrDnsSwBBI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1260540.RA9ys5KJRxwk5fwIMW2mFXrkcjNWxtjnxbqMrDnsSwBBI130_assertion type Assertion NP1260540.RA9ys5KJRxwk5fwIMW2mFXrkcjNWxtjnxbqMrDnsSwBBI130_head.
- NP1260540.RA9ys5KJRxwk5fwIMW2mFXrkcjNWxtjnxbqMrDnsSwBBI130_assertion description "[As IL-4 therapy also improves psoriasis in humans and suppresses IL-23/T(H)17 responses without blocking IL-12/T(H)1, selective IL-4-mediated IL-23/T(H)17 silencing is promising as treatment against harmful inflammation, while sparing the IL-12-dependent T(H)1 responses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260540.RA9ys5KJRxwk5fwIMW2mFXrkcjNWxtjnxbqMrDnsSwBBI130_provenance.
- NP1260540.RA9ys5KJRxwk5fwIMW2mFXrkcjNWxtjnxbqMrDnsSwBBI130_assertion evidence source_evidence_literature NP1260540.RA9ys5KJRxwk5fwIMW2mFXrkcjNWxtjnxbqMrDnsSwBBI130_provenance.
- NP1260540.RA9ys5KJRxwk5fwIMW2mFXrkcjNWxtjnxbqMrDnsSwBBI130_assertion SIO_000772 25646481 NP1260540.RA9ys5KJRxwk5fwIMW2mFXrkcjNWxtjnxbqMrDnsSwBBI130_provenance.
- NP1260540.RA9ys5KJRxwk5fwIMW2mFXrkcjNWxtjnxbqMrDnsSwBBI130_assertion wasDerivedFrom befree-2016 NP1260540.RA9ys5KJRxwk5fwIMW2mFXrkcjNWxtjnxbqMrDnsSwBBI130_provenance.
- NP1260540.RA9ys5KJRxwk5fwIMW2mFXrkcjNWxtjnxbqMrDnsSwBBI130_assertion wasGeneratedBy ECO_0000203 NP1260540.RA9ys5KJRxwk5fwIMW2mFXrkcjNWxtjnxbqMrDnsSwBBI130_provenance.